 | • レポートコード：D0GIR-00559 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、自己免疫治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。自己免疫治療薬の種類別市場規模（関節リウマチ（RA）、多発性硬化症（MS）、乾癬、炎症性腸疾患（IBD）、強直性脊椎炎（AS）、全身性エリテマトーデス（SLE））、用途別市場規模（病院、在宅医療、専門クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Eli Lilly、Roche、Johnson & Johnson、GSK、Pfizer、AbbVie、Amgen、Biogen、Baxter ・地域別グローバル市場分析 2015年-2020年 ・自己免疫治療薬の北米市場（アメリカ、カナダ、メキシコ） ・自己免疫治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・自己免疫治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・自己免疫治療薬の南米市場（ブラジル、アルゼンチン） ・自己免疫治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：関節リウマチ（RA）、多発性硬化症（MS）、乾癬、炎症性腸疾患（IBD）、強直性脊椎炎（AS）、全身性エリテマトーデス（SLE） ・用途別分析：病院、在宅医療、専門クリニック ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Autoimmune Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Autoimmune Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Autoimmune Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Autoimmune Drugs market has been segmented into:
Rheumatoid Arthritis (RA)
Multiple Sclerosis (MS)
Psoriasis
Inflammatory Bowel Disease (IBD)
Ankylosing Spondylitis (AS)
Systemic Lupus Erythematosus (SLE)
By Application, Autoimmune Drugs has been segmented into:
Hospitals
Homecare Settings
Specialty Clinics
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Autoimmune Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Autoimmune Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Autoimmune Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Autoimmune Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Autoimmune Drugs Market Share Analysis
Autoimmune Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Autoimmune Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Autoimmune Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Autoimmune Drugs are:
Eli Lilly
Roche
Johnson & Johnson
GSK
Pfizer
AbbVie
Amgen
Biogen
Baxter
Table of Contents
1 Autoimmune Drugs Market Overview
1.1 Product Overview and Scope of Autoimmune Drugs
1.2 Classification of Autoimmune Drugs by Type
1.2.1 Global Autoimmune Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Autoimmune Drugs Revenue Market Share by Type in 2019
1.2.3 Rheumatoid Arthritis (RA)
1.2.4 Multiple Sclerosis (MS)
1.2.5 Psoriasis
1.2.6 Inflammatory Bowel Disease (IBD)
1.2.7 Ankylosing Spondylitis (AS)
1.2.8 Systemic Lupus Erythematosus (SLE)
1.3 Global Autoimmune Drugs Market by Application
1.3.1 Overview: Global Autoimmune Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Homecare Settings
1.3.4 Specialty Clinics
1.4 Global Autoimmune Drugs Market by Regions
1.4.1 Global Autoimmune Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Autoimmune Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Autoimmune Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Autoimmune Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Autoimmune Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Autoimmune Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Autoimmune Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Eli Lilly SWOT Analysis
2.1.4 Eli Lilly Product and Services
2.1.5 Eli Lilly Autoimmune Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Roche SWOT Analysis
2.2.4 Roche Product and Services
2.2.5 Roche Autoimmune Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Autoimmune Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GSK SWOT Analysis
2.4.4 GSK Product and Services
2.4.5 GSK Autoimmune Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer SWOT Analysis
2.5.4 Pfizer Product and Services
2.5.5 Pfizer Autoimmune Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AbbVie SWOT Analysis
2.6.4 AbbVie Product and Services
2.6.5 AbbVie Autoimmune Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Amgen
2.7.1 Amgen Details
2.7.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Amgen SWOT Analysis
2.7.4 Amgen Product and Services
2.7.5 Amgen Autoimmune Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Biogen
2.8.1 Biogen Details
2.8.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Biogen SWOT Analysis
2.8.4 Biogen Product and Services
2.8.5 Biogen Autoimmune Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Baxter
2.9.1 Baxter Details
2.9.2 Baxter Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Baxter SWOT Analysis
2.9.4 Baxter Product and Services
2.9.5 Baxter Autoimmune Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Autoimmune Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Autoimmune Drugs Players Market Share
3.2.2 Top 10 Autoimmune Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Autoimmune Drugs Revenue and Market Share by Regions
4.2 North America Autoimmune Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Autoimmune Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Autoimmune Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Autoimmune Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Autoimmune Drugs Revenue and Growth Rate (2015-2020)
5 North America Autoimmune Drugs Revenue by Countries
5.1 North America Autoimmune Drugs Revenue by Countries (2015-2020)
5.2 USA Autoimmune Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Autoimmune Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Autoimmune Drugs Revenue and Growth Rate (2015-2020)
6 Europe Autoimmune Drugs Revenue by Countries
6.1 Europe Autoimmune Drugs Revenue by Countries (2015-2020)
6.2 Germany Autoimmune Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Autoimmune Drugs Revenue and Growth Rate (2015-2020)
6.4 France Autoimmune Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Autoimmune Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Autoimmune Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Autoimmune Drugs Revenue by Countries
7.1 Asia-Pacific Autoimmune Drugs Revenue by Countries (2015-2020)
7.2 China Autoimmune Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Autoimmune Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Autoimmune Drugs Revenue and Growth Rate (2015-2020)
7.5 India Autoimmune Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Autoimmune Drugs Revenue and Growth Rate (2015-2020)
8 South America Autoimmune Drugs Revenue by Countries
8.1 South America Autoimmune Drugs Revenue by Countries (2015-2020)
8.2 Brazil Autoimmune Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Autoimmune Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Autoimmune Drugs by Countries
9.1 Middle East & Africa Autoimmune Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Autoimmune Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Autoimmune Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Autoimmune Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Autoimmune Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Autoimmune Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Autoimmune Drugs Market Forecast by Type (2019-2024)
10.3 Rheumatoid Arthritis (RA) Revenue Growth Rate (2015-2025)
10.4 Multiple Sclerosis (MS) Revenue Growth Rate (2015-2025)
10.5 Psoriasis Revenue Growth Rate (2015-2025)
10.6 Inflammatory Bowel Disease (IBD) Revenue Growth Rate (2015-2025)
10.7 Ankylosing Spondylitis (AS) Revenue Growth Rate (2015-2025)
10.8 Systemic Lupus Erythematosus (SLE) Revenue Growth Rate (2015-2025)
11 Global Autoimmune Drugs Market Segment by Application
11.1 Global Autoimmune Drugs Revenue Market Share by Application (2015-2020)
11.2 Autoimmune Drugs Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Homecare Settings Revenue Growth (2015-2020)
11.5 Specialty Clinics Revenue Growth (2015-2020)
12 Global Autoimmune Drugs Market Size Forecast (2021-2025)
12.1 Global Autoimmune Drugs Market Size Forecast (2021-2025)
12.2 Global Autoimmune Drugs Market Forecast by Regions (2021-2025)
12.3 North America Autoimmune Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Autoimmune Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Autoimmune Drugs Revenue Market Forecast (2021-2025)
12.6 South America Autoimmune Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Autoimmune Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Autoimmune Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Autoimmune Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Autoimmune Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Autoimmune Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Eli Lilly Corporate Information, Location and Competitors
Table 6. Eli Lilly Autoimmune Drugs Major Business
Table 7. Eli Lilly Autoimmune Drugs Total Revenue (USD Million) (2017-2018)
Table 8. Eli Lilly SWOT Analysis
Table 9. Eli Lilly Autoimmune Drugs Product and Solutions
Table 10. Eli Lilly Autoimmune Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Roche Corporate Information, Location and Competitors
Table 12. Roche Autoimmune Drugs Major Business
Table 13. Roche Autoimmune Drugs Total Revenue (USD Million) (2018-2019)
Table 14. Roche SWOT Analysis
Table 15. Roche Autoimmune Drugs Product and Solutions
Table 16. Roche Autoimmune Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Johnson & Johnson Corporate Information, Location and Competitors
Table 18. Johnson & Johnson Autoimmune Drugs Major Business
Table 19. Johnson & Johnson Autoimmune Drugs Total Revenue (USD Million) (2017-2018)
Table 20. Johnson & Johnson SWOT Analysis
Table 21. Johnson & Johnson Autoimmune Drugs Product and Solutions
Table 22. Johnson & Johnson Autoimmune Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. GSK Corporate Information, Location and Competitors
Table 24. GSK Autoimmune Drugs Major Business
Table 25. GSK Autoimmune Drugs Total Revenue (USD Million) (2017-2018)
Table 26. GSK SWOT Analysis
Table 27. GSK Autoimmune Drugs Product and Solutions
Table 28. GSK Autoimmune Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Pfizer Corporate Information, Location and Competitors
Table 30. Pfizer Autoimmune Drugs Major Business
Table 31. Pfizer Autoimmune Drugs Total Revenue (USD Million) (2017-2018)
Table 32. Pfizer SWOT Analysis
Table 33. Pfizer Autoimmune Drugs Product and Solutions
Table 34. Pfizer Autoimmune Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. AbbVie Corporate Information, Location and Competitors
Table 36. AbbVie Autoimmune Drugs Major Business
Table 37. AbbVie Autoimmune Drugs Total Revenue (USD Million) (2017-2018)
Table 38. AbbVie SWOT Analysis
Table 39. AbbVie Autoimmune Drugs Product and Solutions
Table 40. AbbVie Autoimmune Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Amgen Corporate Information, Location and Competitors
Table 42. Amgen Autoimmune Drugs Major Business
Table 43. Amgen Autoimmune Drugs Total Revenue (USD Million) (2017-2018)
Table 44. Amgen SWOT Analysis
Table 45. Amgen Autoimmune Drugs Product and Solutions
Table 46. Amgen Autoimmune Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Biogen Corporate Information, Location and Competitors
Table 48. Biogen Autoimmune Drugs Major Business
Table 49. Biogen Autoimmune Drugs Total Revenue (USD Million) (2017-2018)
Table 50. Biogen SWOT Analysis
Table 51. Biogen Autoimmune Drugs Product and Solutions
Table 52. Biogen Autoimmune Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Baxter Corporate Information, Location and Competitors
Table 54. Baxter Autoimmune Drugs Major Business
Table 55. Baxter Autoimmune Drugs Total Revenue (USD Million) (2017-2018)
Table 56. Baxter SWOT Analysis
Table 57. Baxter Autoimmune Drugs Product and Solutions
Table 58. Baxter Autoimmune Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Autoimmune Drugs Revenue (Million USD) by Players (2015-2020)
Table 60. Global Autoimmune Drugs Revenue Share by Players (2015-2020)
Table 61. Global Autoimmune Drugs Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Autoimmune Drugs Revenue Market Share by Regions (2015-2020)
Table 63. North America Autoimmune Drugs Revenue by Countries (2015-2020)
Table 64. North America Autoimmune Drugs Revenue Market Share by Countries (2015-2020)
Table 65. Europe Autoimmune Drugs Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Autoimmune Drugs Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Autoimmune Drugs Revenue by Countries (2015-2020)
Table 68. South America Autoimmune Drugs Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Autoimmune Drugs Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Autoimmune Drugs Revenue Market Share by Countries (2015-2020)
Table 71. Global Autoimmune Drugs Revenue (Million USD) by Type (2015-2020)
Table 72. Global Autoimmune Drugs Revenue Share by Type (2015-2020)
Table 73. Global Autoimmune Drugs Revenue Forecast by Type (2021-2025)
Table 74. Global Autoimmune Drugs Revenue by Application (2015-2020)
Table 75. Global Autoimmune Drugs Revenue Share by Application (2015-2020)
Table 76. Global Autoimmune Drugs Revenue Forecast by Application (2021-2025)
Table 77. Global Autoimmune Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Autoimmune Drugs Picture
Figure 2. Global Autoimmune Drugs Revenue Market Share by Type in 2019
Figure 3. Rheumatoid Arthritis (RA) Picture
Figure 4. Multiple Sclerosis (MS) Picture
Figure 5. Psoriasis Picture
Figure 6. Inflammatory Bowel Disease (IBD) Picture
Figure 7. Ankylosing Spondylitis (AS) Picture
Figure 8. Systemic Lupus Erythematosus (SLE) Picture
Figure 9. Autoimmune Drugs Revenue Market Share by Application in 2019
Figure 10. Hospitals Picture
Figure 11. Homecare Settings Picture
Figure 12. Specialty Clinics Picture
Figure 13. Global Autoimmune Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Autoimmune Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Autoimmune Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Autoimmune Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Autoimmune Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Autoimmune Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Autoimmune Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Autoimmune Drugs Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Autoimmune Drugs Revenue Market Share in 2019
Figure 22. Global Top 10 Players Autoimmune Drugs Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Autoimmune Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Autoimmune Drugs Revenue Market Share by Regions (2015-2020)
Figure 26. Global Autoimmune Drugs Revenue Market Share by Regions in 2018
Figure 27. North America Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 28. Europe Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 30. South America Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 32. North America Autoimmune Drugs Revenue Market Share by Countries (2015-2020)
Figure 33. North America Autoimmune Drugs Revenue Market Share by Countries in 2019
Figure 34. USA Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 35. Canada Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 37. Europe Autoimmune Drugs Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Autoimmune Drugs Revenue Market Share by Countries in 2019
Figure 39. Germany Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 40. UK Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 41. France Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 42. Russia Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 43. Italy Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Autoimmune Drugs Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Autoimmune Drugs Revenue Market Share by Countries in 2019
Figure 46. China Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 47. Japan Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 48. Korea Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 49. India Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 51. South America Autoimmune Drugs Revenue Market Share by Countries (2015-2020)
Figure 52. South America Autoimmune Drugs Revenue Market Share by Countries in 2019
Figure 53. Brazil Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Autoimmune Drugs Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Autoimmune Drugs Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 58. UAE Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Autoimmune Drugs Revenue and Growth Rate (2015-2020)
Figure 61. Global Autoimmune Drugs Revenue Share by Type (2015-2020)
Figure 62. Global Autoimmune Drugs Revenue Share by Type in 2019
Figure 63. Global Autoimmune Drugs Market Share Forecast by Type (2021-2025)
Figure 64. Global Rheumatoid Arthritis (RA) Revenue Growth Rate (2015-2020)
Figure 65. Global Multiple Sclerosis (MS) Revenue Growth Rate (2015-2020)
Figure 66. Global Psoriasis Revenue Growth Rate (2015-2020)
Figure 67. Global Inflammatory Bowel Disease (IBD) Revenue Growth Rate (2015-2020)
Figure 68. Global Ankylosing Spondylitis (AS) Revenue Growth Rate (2015-2020)
Figure 69. Global Systemic Lupus Erythematosus (SLE) Revenue Growth Rate (2015-2020)
Figure 70. Global Autoimmune Drugs Revenue Share by Application (2015-2020)
Figure 71. Global Autoimmune Drugs Revenue Share by Application in 2019
Figure 72. Global Autoimmune Drugs Market Share Forecast by Application (2021-2025)
Figure 73. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 74. Global Homecare Settings Revenue Growth Rate (2015-2020)
Figure 75. Global Specialty Clinics Revenue Growth Rate (2015-2020)
Figure 76. Global Autoimmune Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Autoimmune Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Autoimmune Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Autoimmune Drugs Revenue Market Forecast (2021-2025)
Figure 80. Europe Autoimmune Drugs Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Autoimmune Drugs Revenue Market Forecast (2021-2025)
Figure 82. South America Autoimmune Drugs Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Autoimmune Drugs Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
自己免疫疾患診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Diagnosis of Autoimmune Diseases market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…- 自己免疫疾患治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Autoimmune Disorders Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Autoimmune Dis…
- メニエール病治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Meniere's Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Meniere's Disease Dru…
- セリアック病治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Celiac Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Celiac Disease Drugs mar…
- 非ステロイド性抗炎症薬（NSAID）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The…